Ilico Genetics
Biotechnology Research
116 Research Dr
6 employees
- Employees
- 6
Ilico Genetics Overview
- Headquarters
- 116 Research Dr
- Website
- www.ilicogenetics.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2020
- Funding
- 540.0K
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Ilico Genetics
Ilico Genetics, a Spin Off of Pontificia Universidad Católica de Chile, is developing the first methylated DNA based molecular test specifically designed for the early detection of gastric cancer, even years before Esophagogastroduodenoscopy (EGD, gold standard). With only a blood sample, and even without symptoms, it detects a tumor in the stomach or lesions that could evolve to gastric cancer. The results are dynamic and show the cumulative presence of tumors over time.
Ilico Genetics Contact Details
- People in AeroLeads
- 4
Ilico Genetics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Ginette Morue |
View
|
||
| Matthew West | Lead Developer at Ilico Genetics | Bethlehem, Pennsylvania, United States |
View
|
| Maria Jose Maturana Rojas | Biochemist, Master in Molecular | United States |
View
|
| Nicholas Fiore-Mcclain | Student at West Chester University |
View
|
Employees by Management Level
Individual contributor
2 profiles
Senior / Lead
1 profile
Compare Similar Companies to Ilico Genetics
Actuated Medical, Inc.
Medical Equipment Manufacturing
Flamingo Therapeutics
Biotechnology Research
ImmunoGenesis, Inc.
Biotechnology Research
XyloCor Therapeutics, Inc.
Research Services
Geneos Therapeutics
Biotechnology Research
Thread Bioscience Inc
Biotechnology Research
Orbits Oncology
Software Development
BaseCure Therapeutics Inc.
Pharmaceutical Manufacturing
BioLattice
Biotechnology Research
Synergy Therapeutics
Biotechnology Research